Induced Pluripotent Stem Cells Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Induced Pluripotent Stem Cells Market: By Technology (Cell Production, Cell Acquisition, Expansion and Sub-Culture, Cryopreservation, and Cryopreservation), By End User (Academic Institutions, Research Institutes, Biotechnology Companies, and Others), and Geography 

 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Induced Pluripotent Stem Cells Market size is valued at USD 1678.54 million in 2021 and is expected to reach USD 2876.72 million by 2028, at a CAGR of 8.0% during the forecast period 2022-2028. Pluripotent stem cells are embryonic stem cells with the ability to develop into any adult cell type and aid in the repair of damaged tissues in the human body. Induced pluripotent stem cells, or iPSCs, are stem cells that have been genetically manipulated to act like pluripotent stem cells or embryonic stem cells. They can be collected from any tissue (typically skin or blood) from a child or an adult. The market for induced pluripotent stem cells is growing due to its ability to produce any cell or tissue the body requires. These cells can potentially be customised to provide a perfect genetic match for any patient suffering from diseases such as diabetes, spinal cord injury, leukaemia, or heart disease. Furthermore, these cells are really beneficial in comprehending. The report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global Induced Pluripotent Stem Cells Market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global Induced Pluripotent Stem Cells Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).

Key Development:

In March 2015, FUJIFILM Holdings Corporation acquired Cellular Dynamics International, Inc.

Induced Pluripotent Stem Cells Market

MARKET SUMMARY
-
8.0%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 8.0%
  • Largest Market– Europe
  • Fastest Growing Market– North-America

Induced Pluripotent Stem Cells Market

  • The global Induced Pluripotent Stem Cells Market report gives comprehensive outlook on Induced Pluripotent Stem Cells Market across the globe with special emphasis on key regions such as Asia Pacific, North America, Europe, Latin America, and Middle East and Africa.
  • The report on global Induced Pluripotent Stem Cells Market gives historical, current, and future market sizes (US$ Mn) on the basis of type, end-user and Region.
key players
  • Acelity Holdings, Inc. (U.S)
  • StemCells, Inc. (U.S)
  • Japan Tissue Engineering Co., Ltd. (Japan)
  • Organogenesis Inc (U.S)
  • Fujifilm Holding Corporation (Japan)
Induced Pluripotent Stem Cells Market

DRIVERS AND RESTRAINTS

The market for induced pluripotent stem cells (iPSCs) is driven by expanding adoption of stem cell therapies, a developing biotechnology sector with better funding, and the rising prevalence of chronic diseases. The wide range of clinical applications of induced pluripotent stem cells and increasing technological improvements of iPSCs are expected to boost the growth of the global induced pluripotent stem cells (iPSCs) market.


North-America got significant share

Induced Pluripotent Stem Cells Market

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East
Induced Pluripotent Stem Cells Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The induced pluripotent stem cells market is projected to expand at a CAGR of 8.0% during the forecast period.

North America is the fastest-growing region for induced pluripotent stem cells market

Acelity Holdings, StemCells, Fujifilm Holding Corporation, Organogenesis Inc


Report

Table Of Content


Report

Company Profile

  • Acelity Holdings, Inc. (U.S)
  • StemCells, Inc. (U.S)
  • Japan Tissue Engineering Co., Ltd. (Japan)
  • Organogenesis Inc (U.S)
  • Fujifilm Holding Corporation (Japan)
  • Fate Therapeutics (U.S)
  • Bristol-Myers Squibb Company (U.S)

Description

Induced Pluripotent Stem Cells Market size is valued at USD 1678.54 million in 2021 and is expected to reach USD 2876.72 million by 2028, at a CAGR of 8.0% during the forecast period 2022-2028. Pluripotent stem cells are embryonic stem cells with the ability to develop into any adult cell type and aid in the repair of damaged tissues in the human body. Induced pluripotent stem cells, or iPSCs, are stem cells that have been genetically manipulated to act like pluripotent stem cells or embryonic stem cells. They can be collected from any tissue (typically skin or blood) from a child or an adult. The market for induced pluripotent stem cells is growing due to its ability to produce any cell or tissue the body requires. These cells can potentially be customised to provide a perfect genetic match for any patient suffering from diseases such as diabetes, spinal cord injury, leukaemia, or heart disease. Furthermore, these cells are really beneficial in comprehending. The report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global Induced Pluripotent Stem Cells Market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global Induced Pluripotent Stem Cells Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).

Key Development:

In March 2015, FUJIFILM Holdings Corporation acquired Cellular Dynamics International, Inc.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX